Copy of News

TriAltus Bioscience Granted U.S. Patent for CL7 Tag Technology

MarketWatch: August 25, 2021

TriAltus Bioscience Launches CLīM™Affinity Tag System, reinventing the way genetically engineered proteins are purified

BioSpace: July 20, 2021

Alabama researchers energize efforts to aid search for COVID-19 therapies

Made in Alabama: May 04, 2020

Birmingham company’s technology to be used in COVID-19 vaccine trial

Birmingham Business Journal: April 17, 2020

Birmingham company spotlights work in gene editing field

AL.com: January 20, 2020

TriAltus Bioscience to Present Abstract on Single-Step Cas9 Protein Purification with CL7/Im7 Affinity Tag System at PepTalk 2020

TriAltus: January 14, 2020